Quality Of Life

BOSTON — Based on patient responses, quality of life with idiopathic pulmonary fibrosis was worse among those treated in community pulmonary practices vs. interstitial lung disease centers, according to data at the CHEST Annual Meeting.

SAN ANTONIO — In patients with obesity, the novel triple receptor agonist retatrutide was associated with improvement in health-related quality of life vs. placebo, a speaker reported.

In patients with severe tricuspid regurgitation, transcatheter tricuspid valve replacement plus medical therapy improved outcomes compared with medical therapy alone, researchers reported at TCT 2024.

BOSTON — Patients with hereditary angioedema who used deucrictibant for 12 weeks experienced improved symptom control, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Breast cancer survivors who participated in a remote personalized exercise program experienced modest improvements in quality of life, according to results from the eMouvoir trial presented at ESMO Congress.

WASHINGTON — In patients with moderate aortic stenosis and HF with reduced ejection fraction, transcatheter aortic valve replacement did not improve clinical outcomes but may raise quality of life vs. clinical surveillance, data show.

BOSTON — Lung function, symptoms and quality of life improved with receipt of ensifentrine in both adults with moderate COPD and adults with severe COPD, according to data presented at the CHEST Annual Meeting.

Patients who underwent a single treatment with TearCare experienced significant improvements in reading speed, as well as signs and symptoms of dry eye disease, 1 month after the procedure, according to a study in Clinical Ophthalmology.

Baroreflex activation therapy plus optimal medical therapy improved quality of life at 2 years in patients with HF with reduced ejection fraction compared with optimal medical therapy alone, researchers reported.

BOSTON — Receiving dupilumab for 52 weeks led to health-related quality of life improvement in adults with COPD and type 2 inflammation, according to a pooled analysis of BOREAS and NOTUS presented at the CHEST Annual Meeting.